Tiziana Life Sciences Ltd (TLSA) stock
TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81+0.16 (+24.37%)
Close on Nov 18, 2026Market cap $97.42MP/E –Yield –
Tiziana Life Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$12.87M. The highest annual figure on record is -$1.55M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.87M | – |
| FY2024 | Dec 31, 2024 | -$1.55M | – |
| FY2021 | Dec 31, 2021 | -$21.78M | – |
| FY2020 | Dec 31, 2020 | -$11.34M | – |
| FY2019 | Dec 31, 2019 | -$6.80M | – |
| FY2017 | Dec 31, 2017 | -$7.53M | – |
See a number that looks wrong?